Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Merger agrmnt [a]
Quarterly results
CC transcript
Inv. presentation
Director departure
Appointed director
AMICUS THERAPEUTICS, INC. (FOLD) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/09/2022 8-K/A Quarterly results
06/23/2014 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated 2007 Equity Incentive Plan"
02/12/2014 8-K/A Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Amicus Therapeutics, Inc., CB Acquisition Corp., Callidus Biopharma, Inc. and Cuong Do"
02/04/2014 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Windham Brannon, P.C., Independent Certified Public Accountants for Callidus Biopharma, Inc",
"Consent of Windham Brannon, P.C., Independent Certified Public Accountants for Callidus Biopharma, Inc",
"Audited financial statements of Callidus Biopharma, Inc., as of and for the years ended December 31, 2012 and 2011",
"Unaudited financial statements of Callidus Biopharma, Inc., as of September 30, 2013 and for the nine months ended September 30, 2013 and 2012",
"Unaudited financial statements of Callidus Biopharma, Inc., as of September 30, 2013 and for the nine months ended September 30, 2013 and 2012",
"Unaudited Pro Forma Financial Information listed in Item 9.01(b)",
"Unaudited Pro Forma Financial Information listed in Item 9.01(b)"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy